PIPELINE WATCH – Six approvals, two launches and a market discontinuation
This article was originally published in Scrip
Executive Summary
This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.